Results 91 to 100 of about 1,738 (148)

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study. [PDF]

open access: yesAnn Hematol
Lv Y   +14 more
europepmc   +1 more source

Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient [PDF]

open access: yes
A Etzioni   +43 more
core   +1 more source

Expanded CD16<sup>+</sup>CD56<sup>+</sup>Granzyme B<sup>+</sup> NK like CD8<sup>+</sup> T cells an off target effect of bruton's tyrosine kinase inhibitors in Waldenström macroglobulinemia. [PDF]

open access: yesSci Rep
Hastak P   +16 more
europepmc   +1 more source

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma. [PDF]

open access: yesBlood Adv
Dutta RP   +11 more
europepmc   +1 more source

Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B Cells. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Dybowski S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy